Page 109 - GPD-3-4
P. 109

Gene & Protein in Disease                                           Pre-metastatic niche oral cancer: Insights




            Table 4. (Continued)
            Term                %      P‑value           Genes            Fold    Bonferroni  Benjamini  FDR
                                                                        enrichment
            hsa05310: Asthma  0.75650118  8.65E-07  HLA‑DQB1, FCER1A, TNF,   4.11366164  1.59E-04  1.45E-05  0.0010698
                                                IL5, HLA‑DRB1, HLA‑DRB3,
                                                CD40, HLA‑DMB, HLA‑DMA,
                                                HLA‑DQA2, HLA‑DQA1,
                                                CD40LG, HLA‑DPA1, HLA‑DOA,
                                                HLA‑DOB, HLA‑DRA
            hsa04060:        3.02600473  1.16E-06  IL21R, FASLG, CXCR2, IL15,   1.82131584  2.13E-04  1.77E-05  0.00142939
            Cytokine-cytokine                   TNFSF12, CXCL12, IL11,
            receptor interaction                FLT3LG, ACVR1B, TNFRSF11B,
                                                CXCR5, CXCR4, IL4R, LTB,
                                                LTA, CSF2RA, GHR, TNFRSF17,
                                                TNFRSF14, IL6R, CD40, CCR9,
                                                TNFRSF10A, IFNAR2, TNFRSF9,
                                                CCR7, TNFRSF10B, RELT, CCR4,
                                                CD40LG, CCR3, CX3CR1, IL12A,
                                                NGFR, CSF3, TNF, CXCL5,
                                                TNFRSF25, CXCL2, TNFRSF8,
                                                PF4, KIT, IL7R, CCL22,
                                                TNFRSF1B, IL23A, IL12RB1,
                                                CCL20, CCL21, IL10RA, IL2RG,
                                                CD27, IL2RB, IL23R, IL5, IL7,
                                                FLT3, CCL19, KDR, CCL17,
                                                TSLP, CCL14, CXCL13, IL3RA
            hsa04664: Fc epsilon   1.32387707  1.28E-06  TNF, BTK, KRAS, RAC2, PIK3CA,   2.67651703  2.36E-04  1.81E-05  0.00158281
            RI signaling pathway                PIK3R5, INPP5D, AKT3, AKT2,
                                                SYK, PRKCA, PIK3CG, FCER1A,
                                                IL5, LYN, PIK3CD, MAP2K4,
                                                VAV1, PRKCB, MAPK1, LAT,
                                                PLA2G4A, PLCG1, FYN, PLCG2,
                                                MAPK8, PLA2G2D, LCP2
            hsa05332:        0.85106383  3.39E-06  HLA‑DQB1, TNF, HLA‑DRB1,   3.44123618  6.24E-04  4.46E-05  0.00419502
            Graft-versus-host                   HLA‑DRB3, FASLG, GZMB,
            disease                             HLA‑DMB, HLA‑E, HLA‑DQA2,
                                                HLA‑DMA, HLA‑DQA1, HLA‑G,
                                                HLA‑F, HLA‑DPA1, HLA‑DOA,
                                                HLA‑DOB, CD28, HLA‑DRA
            hsa05320:        0.9929078  3.46E-06  HLA‑DQB1, IL5, HLA‑DRB1,   3.07012248  6.36E-04  4.24E-05  0.00427531
            Autoimmune thyroid                  HLA‑DRB3, CTLA4, FASLG,
            disease                             GZMB, CD40, HLA‑DMB,
                                                HLA‑E, HLA‑DQA2, HLA‑DMA,
                                                HLA‑DQA1, HLA‑G, HLA‑F,
                                                CD40LG, HLA‑DPA1, HLA‑DOA,
                                                HLA‑DOB, CD28, HLA‑DRA
            hsa04666: Fc     1.37115839  2.73E-05  MARCKSL1, PIP5K1B, ARPC4,   2.27604569  0.0050155  3.14E-04  0.0337775
            gamma R-mediated                    PIP5K1A, DOCK2, RAC2,
            phagocytosis                        PIKFYVE, PIK3CA, PIK3R5,
                                                INPP5D, AKT3, SYK, AKT2,
                                                PRKCA, PIK3CG, PTPRC, LYN,
                                                NCF1, HCK, PIK3CD, VAV1,
                                                PRKCB, MAPK1, LAT, PLA2G4A,
                                                PLCG1, FCGR2B, CFL2, PLCG2
            hsa05223: Non-small   0.89834515  1.34E-04  PRKCA, PIK3CG, FHIT, BRAF,   2.62341153  0.02430181  0.00144613  0.16516041
            cell lung cancer                    RXRB, PIK3CD, TP53, STK4,
                                                PRKCB, MAPK1, RASSF5, KRAS,
                                                PLCG1, CASP9, PLCG2, PIK3CA,
                                                PIK3R5, AKT3, AKT2
                                                                                                       (Cont’d...)

            Volume 3 Issue 4 (2024)                         12                              doi: 10.36922/gpd.2971
   104   105   106   107   108   109   110   111   112   113   114